China National Accord Medicines Corp Ltd (200028) - Cash Flow Conversion Efficiency
Based on the latest financial reports, China National Accord Medicines Corp Ltd (200028) has a cash flow conversion efficiency ratio of -0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (HK$-424.00 Million ≈ $-54.13 Million USD) by net assets (HK$21.55 Billion ≈ $2.75 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see China National Accord Medicines Corp Ltd (200028) total market value for the company's overall valuation and market capitalisation.
China National Accord Medicines Corp Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how China National Accord Medicines Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
China National Accord Medicines Corp Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of China National Accord Medicines Corp Ltd ranked by their cash flow conversion efficiency. Explore China National Accord Medicines Corp Ltd (200028) cash flow quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
OM Holdings Ltd
KLSE:5298
|
-0.004x |
|
Khonburi Sugar Public Company Limited
BK:KBS
|
0.252x |
|
BEC World Public Company Limited
BK:BEC
|
0.049x |
|
Sangoma Technologies Corp
TO:STC
|
0.046x |
|
S.Kijchai Enterprise Public Company Limited
BK:SKN
|
0.017x |
|
Stel Holdings Limited
NSE:STEL
|
0.005x |
|
Yeong Hwa Meta
KO:012280
|
0.097x |
|
Silitech Technology Corp
TW:3311
|
-0.002x |
Annual Cash Flow Conversion Efficiency for China National Accord Medicines Corp Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of China National Accord Medicines Corp Ltd from 1998 to 2025. View 200028 stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | HK$21.62 Billion ≈ $2.76 Billion |
HK$1.64 Billion ≈ $209.17 Million |
0.076x | -51.93% |
| 2024-12-31 | HK$20.76 Billion ≈ $2.65 Billion |
HK$3.27 Billion ≈ $417.62 Million |
0.158x | +12.58% |
| 2023-12-31 | HK$20.98 Billion ≈ $2.68 Billion |
HK$2.94 Billion ≈ $374.94 Million |
0.140x | +6.33% |
| 2022-12-31 | HK$19.44 Billion ≈ $2.48 Billion |
HK$2.56 Billion ≈ $326.85 Million |
0.132x | +43.38% |
| 2021-12-31 | HK$18.02 Billion ≈ $2.30 Billion |
HK$1.66 Billion ≈ $211.29 Million |
0.092x | +3.22% |
| 2020-12-31 | HK$16.89 Billion ≈ $2.16 Billion |
HK$1.50 Billion ≈ $191.83 Million |
0.089x | -31.68% |
| 2019-12-31 | HK$15.36 Billion ≈ $1.96 Billion |
HK$2.00 Billion ≈ $255.35 Million |
0.130x | +36.93% |
| 2018-12-31 | HK$13.91 Billion ≈ $1.78 Billion |
HK$1.32 Billion ≈ $168.84 Million |
0.095x | -26.54% |
| 2017-12-31 | HK$9.93 Billion ≈ $1.27 Billion |
HK$1.29 Billion ≈ $164.07 Million |
0.129x | -21.63% |
| 2016-12-31 | HK$8.91 Billion ≈ $1.14 Billion |
HK$1.47 Billion ≈ $187.98 Million |
0.165x | -12.25% |
| 2015-12-31 | HK$5.57 Billion ≈ $710.58 Million |
HK$1.05 Billion ≈ $133.78 Million |
0.188x | +214.64% |
| 2014-12-31 | HK$4.85 Billion ≈ $619.28 Million |
HK$-796.70 Million ≈ $-101.70 Million |
-0.164x | -181.81% |
| 2013-12-31 | HK$2.32 Billion ≈ $295.73 Million |
HK$465.03 Million ≈ $59.36 Million |
0.201x | +13.95% |
| 2012-12-31 | HK$1.84 Billion ≈ $234.76 Million |
HK$323.96 Million ≈ $41.35 Million |
0.176x | +10.57% |
| 2011-12-31 | HK$1.43 Billion ≈ $182.14 Million |
HK$227.32 Million ≈ $29.02 Million |
0.159x | -57.90% |
| 2010-12-31 | HK$1.13 Billion ≈ $144.43 Million |
HK$428.16 Million ≈ $54.66 Million |
0.378x | +22.69% |
| 2009-12-31 | HK$878.13 Million ≈ $112.10 Million |
HK$270.85 Million ≈ $34.57 Million |
0.308x | -18.77% |
| 2008-12-31 | HK$649.37 Million ≈ $82.89 Million |
HK$246.58 Million ≈ $31.48 Million |
0.380x | +124.10% |
| 2007-12-31 | HK$517.58 Million ≈ $66.07 Million |
HK$87.70 Million ≈ $11.20 Million |
0.169x | -55.91% |
| 2006-12-31 | HK$472.90 Million ≈ $60.37 Million |
HK$181.73 Million ≈ $23.20 Million |
0.384x | +2.04% |
| 2005-12-31 | HK$393.72 Million ≈ $50.26 Million |
HK$148.28 Million ≈ $18.93 Million |
0.377x | +3.53% |
| 2004-12-31 | HK$358.20 Million ≈ $45.73 Million |
HK$130.30 Million ≈ $16.63 Million |
0.364x | +53.55% |
| 2003-12-31 | HK$342.86 Million ≈ $43.77 Million |
HK$81.22 Million ≈ $10.37 Million |
0.237x | +175.64% |
| 2002-12-31 | HK$334.70 Million ≈ $42.73 Million |
HK$28.76 Million ≈ $3.67 Million |
0.086x | -55.98% |
| 2001-12-31 | HK$364.45 Million ≈ $46.52 Million |
HK$71.16 Million ≈ $9.08 Million |
0.195x | +828.36% |
| 2000-12-31 | HK$405.06 Million ≈ $51.71 Million |
HK$8.52 Million ≈ $1.09 Million |
0.021x | -58.36% |
| 1999-12-31 | HK$452.23 Million ≈ $57.73 Million |
HK$22.84 Million ≈ $2.92 Million |
0.051x | +334.65% |
| 1998-12-31 | HK$448.25 Million ≈ $57.22 Million |
HK$5.21 Million ≈ $664.85K |
0.012x | -- |
About China National Accord Medicines Corp Ltd
China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers new and special drugs and medications for chronic diseases. It also provides traditional Chinese medicine, Western medicine, rehabilitation therapy, and various medical-related resources, as well as chemical drugs, OTC drugs, and healt… Read more